Swot Analysis of "ImmuLogic Pharmaceutical Corp. (B2): Henry McCance" written by Josh Lerner includes – strengths weakness that are internal strategic factors of the organization, and opportunities and threats that Mccance Immulogic facing as an external strategic factors. Some of the topics covered in ImmuLogic Pharmaceutical Corp. (B2): Henry McCance case study are - Strategic Management Strategies, Entrepreneurial management, Financial analysis, Financial management, Financial markets and Finance & Accounting.
Some of the macro environment factors that can be used to understand the ImmuLogic Pharmaceutical Corp. (B2): Henry McCance casestudy better are - – talent flight as more people leaving formal jobs, increasing transportation and logistics costs, banking and financial system is disrupted by Bitcoin and other crypto currencies, cloud computing is disrupting traditional business models, technology disruption, increasing commodity prices, geopolitical disruptions,
there is backlash against globalization, increasing government debt because of Covid-19 spendings, etc
Introduction to SWOT Analysis of ImmuLogic Pharmaceutical Corp. (B2): Henry McCance
SWOT stands for an organization’s Strengths, Weaknesses, Opportunities and Threats . At Oak Spring University , we believe that protagonist in ImmuLogic Pharmaceutical Corp. (B2): Henry McCance case study can use SWOT analysis as a strategic management tool to assess the current internal strengths and weaknesses of the Mccance Immulogic, and to figure out the opportunities and threats in the macro environment – technological, environmental, political, economic, social, demographic, etc in which Mccance Immulogic operates in.
According to Harvard Business Review, 75% of the managers use SWOT analysis for various purposes such as – evaluating current scenario, strategic planning, new venture feasibility, personal growth goals, new market entry, Go To market strategies, portfolio management and strategic trade-off assessment, organizational restructuring, etc.
SWOT Objectives / Importance of SWOT Analysis and SWOT Matrix
SWOT analysis of ImmuLogic Pharmaceutical Corp. (B2): Henry McCance can be done for the following purposes –
1. Strategic planning using facts provided in ImmuLogic Pharmaceutical Corp. (B2): Henry McCance case study
2. Improving business portfolio management of Mccance Immulogic
3. Assessing feasibility of the new initiative in Finance & Accounting field.
4. Making a Finance & Accounting topic specific business decision
5. Set goals for the organization
6. Organizational restructuring of Mccance Immulogic
Strengths ImmuLogic Pharmaceutical Corp. (B2): Henry McCance | Internal Strategic Factors
What are Strengths in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The strengths of Mccance Immulogic in ImmuLogic Pharmaceutical Corp. (B2): Henry McCance Harvard Business Review case study are -
High brand equity
– Mccance Immulogic has strong brand awareness and brand recognition among both - the exiting customers and potential new customers. Strong brand equity has enabled Mccance Immulogic to keep acquiring new customers and building profitable relationship with both the new and loyal customers.
Low bargaining power of suppliers
– Suppliers of Mccance Immulogic in the sector have low bargaining power. ImmuLogic Pharmaceutical Corp. (B2): Henry McCance has further diversified its suppliers portfolio by building a robust supply chain across various countries. This helps Mccance Immulogic to manage not only supply disruptions but also source products at highly competitive prices.
Superior customer experience
– The customer experience strategy of Mccance Immulogic in the segment is based on four key concepts – personalization, simplification of complex needs, prompt response, and continuous engagement.
Effective Research and Development (R&D)
– Mccance Immulogic has innovation driven culture where significant part of the revenues are spent on the research and development activities. This has resulted in, as mentioned in case study ImmuLogic Pharmaceutical Corp. (B2): Henry McCance - staying ahead in the industry in terms of – new product launches, superior customer experience, highly competitive pricing strategies, and great returns to the shareholders.
Training and development
– Mccance Immulogic has one of the best training and development program in the industry. The effectiveness of the training programs can be measured in ImmuLogic Pharmaceutical Corp. (B2): Henry McCance Harvard Business Review case study by analyzing – employees retention, in-house promotion, loyalty, new venture initiation, lack of conflict, and high level of both employees and customer engagement.
Digital Transformation in Finance & Accounting segment
- digital transformation varies from industry to industry. For Mccance Immulogic digital transformation journey comprises differing goals based on market maturity, customer technology acceptance, and organizational culture. Mccance Immulogic has successfully integrated the four key components of digital transformation – digital integration in processes, digital integration in marketing and customer relationship management, digital integration into the value chain, and using technology to explore new products and market opportunities.
Organizational Resilience of Mccance Immulogic
– The covid-19 pandemic has put organizational resilience at the centre of everthing that Mccance Immulogic does. Organizational resilience comprises - Financial Resilience, Operational Resilience, Technological Resilience, Organizational Resilience, Business Model Resilience, and Reputation Resilience.
Ability to recruit top talent
– Mccance Immulogic is one of the leading recruiters in the industry. Managers in the ImmuLogic Pharmaceutical Corp. (B2): Henry McCance are in a position to attract the best talent available. The firm has a robust talent identification program that helps in identifying the brightest.
Sustainable margins compare to other players in Finance & Accounting industry
– ImmuLogic Pharmaceutical Corp. (B2): Henry McCance firm has clearly differentiated products in the market place. This has enabled Mccance Immulogic to fetch slight price premium compare to the competitors in the Finance & Accounting industry. The sustainable margins have also helped Mccance Immulogic to invest into research and development (R&D) and innovation.
Strong track record of project management
– Mccance Immulogic is known for sticking to its project targets. This enables the firm to manage – time, project costs, and have sustainable margins on the projects.
Innovation driven organization
– Mccance Immulogic is one of the most innovative firm in sector. Manager in ImmuLogic Pharmaceutical Corp. (B2): Henry McCance Harvard Business Review case study can use Clayton Christensen Disruptive Innovation strategies to further increase the scale of innovtions in the organization.
Analytics focus
– Mccance Immulogic is putting a lot of focus on utilizing the power of analytics in business decision making. This has put it among the leading players in the industry. The technology infrastructure suggested by Josh Lerner can also help it to harness the power of analytics for – marketing optimization, demand forecasting, customer relationship management, inventory management, information sharing across the value chain etc.
Weaknesses ImmuLogic Pharmaceutical Corp. (B2): Henry McCance | Internal Strategic Factors
What are Weaknesses in SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The weaknesses of ImmuLogic Pharmaceutical Corp. (B2): Henry McCance are -
High dependence on existing supply chain
– The disruption in the global supply chains because of the Covid-19 pandemic and blockage of the Suez Canal illustrated the fragile nature of Mccance Immulogic supply chain. Even after few cautionary changes mentioned in the HBR case study - ImmuLogic Pharmaceutical Corp. (B2): Henry McCance, it is still heavily dependent upon the existing supply chain. The existing supply chain though brings in cost efficiencies but it has left Mccance Immulogic vulnerable to further global disruptions in South East Asia.
Skills based hiring
– The stress on hiring functional specialists at Mccance Immulogic has created an environment where the organization is dominated by functional specialists rather than management generalist. This has resulted into product oriented approach rather than marketing oriented approach or consumers oriented approach.
High dependence on star products
– The top 2 products and services of the firm as mentioned in the ImmuLogic Pharmaceutical Corp. (B2): Henry McCance HBR case study still accounts for major business revenue. This dependence on star products in has resulted into insufficient focus on developing new products, even though Mccance Immulogic has relatively successful track record of launching new products.
Need for greater diversity
– Mccance Immulogic has taken concrete steps on diversity, equity, and inclusion. But the efforts so far has resulted in limited success. It needs to expand the recruitment and selection process to hire more people from the minorities and underprivileged background.
High operating costs
– Compare to the competitors, firm in the HBR case study ImmuLogic Pharmaceutical Corp. (B2): Henry McCance has high operating costs in the. This can be harder to sustain given the new emerging competition from nimble players who are using technology to attract Mccance Immulogic 's lucrative customers.
Slow to harness new channels of communication
– Even though competitors are using new communication channels such as Instagram, Tiktok, and Snap, Mccance Immulogic is slow explore the new channels of communication. These new channels of communication mentioned in marketing section of case study ImmuLogic Pharmaceutical Corp. (B2): Henry McCance can help to provide better information regarding products and services. It can also build an online community to further reach out to potential customers.
Aligning sales with marketing
– It come across in the case study ImmuLogic Pharmaceutical Corp. (B2): Henry McCance that the firm needs to have more collaboration between its sales team and marketing team. Sales professionals in the industry have deep experience in developing customer relationships. Marketing department in the case ImmuLogic Pharmaceutical Corp. (B2): Henry McCance can leverage the sales team experience to cultivate customer relationships as Mccance Immulogic is planning to shift buying processes online.
Low market penetration in new markets
– Outside its home market of Mccance Immulogic, firm in the HBR case study ImmuLogic Pharmaceutical Corp. (B2): Henry McCance needs to spend more promotional, marketing, and advertising efforts to penetrate international markets.
High cash cycle compare to competitors
Mccance Immulogic has a high cash cycle compare to other players in the industry. It needs to shorten the cash cycle by 12% to be more competitive in the marketplace, reduce inventory costs, and be more profitable.
Slow to strategic competitive environment developments
– As ImmuLogic Pharmaceutical Corp. (B2): Henry McCance HBR case study mentions - Mccance Immulogic takes time to assess the upcoming competitions. This has led to missing out on atleast 2-3 big opportunities in the industry in last five years.
Slow decision making process
– As mentioned earlier in the report, Mccance Immulogic has a very deliberative decision making approach. This approach has resulted in prudent decisions, but it has also resulted in missing opportunities in the industry over the last five years. Mccance Immulogic even though has strong showing on digital transformation primary two stages, it has struggled to capitalize the power of digital transformation in marketing efforts and new venture efforts.
Opportunities ImmuLogic Pharmaceutical Corp. (B2): Henry McCance | External Strategic Factors
What are Opportunities in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The opportunities highlighted in the Harvard Business Review case study ImmuLogic Pharmaceutical Corp. (B2): Henry McCance are -
Better consumer reach
– The expansion of the 5G network will help Mccance Immulogic to increase its market reach. Mccance Immulogic will be able to reach out to new customers. Secondly 5G will also provide technology framework to build new tools and products that can help more immersive consumer experience and faster consumer journey.
Buying journey improvements
– Mccance Immulogic can improve the customer journey of consumers in the industry by using analytics and artificial intelligence. ImmuLogic Pharmaceutical Corp. (B2): Henry McCance suggest that firm can provide automated chats to help consumers solve their own problems, provide online suggestions to get maximum out of the products and services, and help consumers to build a community where they can interact with each other to develop new features and uses.
Leveraging digital technologies
– Mccance Immulogic can leverage digital technologies such as artificial intelligence and machine learning to automate the production process, customer analytics to get better insights into consumer behavior, realtime digital dashboards to get better sales tracking, logistics and transportation, product tracking, etc.
Identify volunteer opportunities
– Covid-19 has impacted working population in two ways – it has led to people soul searching about their professional choices, resulting in mass resignation. Secondly it has encouraged people to do things that they are passionate about. This has opened opportunities for businesses to build volunteer oriented socially driven projects. Mccance Immulogic can explore opportunities that can attract volunteers and are consistent with its mission and vision.
Increase in government spending
– As the United States and other governments are increasing social spending and infrastructure spending to build economies post Covid-19, Mccance Immulogic can use these opportunities to build new business models that can help the communities that Mccance Immulogic operates in. Secondly it can use opportunities from government spending in Finance & Accounting sector.
Reconfiguring business model
– The expansion of digital payment system, the bringing down of international transactions costs using Bitcoin and other blockchain based currencies, etc can help Mccance Immulogic to reconfigure its entire business model. For example it can used blockchain based technologies to reduce piracy of its products in the big markets such as China. Secondly it can use the popularity of e-commerce in various developing markets to build a Direct to Customer business model rather than the current Channel Heavy distribution network.
Building a culture of innovation
– managers at Mccance Immulogic can make experimentation a productive activity and build a culture of innovation using approaches such as – mining transaction data, A/B testing of websites and selling platforms, engaging potential customers over various needs, and building on small ideas in the Finance & Accounting segment.
Lowering marketing communication costs
– 5G expansion will open new opportunities for Mccance Immulogic in the field of marketing communication. It will bring down the cost of doing business, provide technology platform to build new products in the Finance & Accounting segment, and it will provide faster access to the consumers.
Manufacturing automation
– Mccance Immulogic can use the latest technology developments to improve its manufacturing and designing process in Finance & Accounting segment. It can use CAD and 3D printing to build a quick prototype and pilot testing products. It can leverage automation using machine learning and artificial intelligence to do faster production at lowers costs, and it can leverage the growth in satellite and tracking technologies to improve inventory management, transportation, and shipping.
Remote work and new talent hiring opportunities
– The widespread usage of remote working technologies during Covid-19 has opened opportunities for Mccance Immulogic to expand its talent hiring zone. According to McKinsey Global Institute, 20% of the high end workforce in fields such as finance, information technology, can continously work from remote local post Covid-19. This presents a really great opportunity for Mccance Immulogic to hire the very best people irrespective of their geographical location.
Finding new ways to collaborate
– Covid-19 has not only transformed business models of companies in Finance & Accounting industry, but it has also influenced the consumer preferences. Mccance Immulogic can tie-up with other value chain partners to explore new opportunities regarding meeting customer demands and building a rewarding and engaging relationship.
Creating value in data economy
– The success of analytics program of Mccance Immulogic has opened avenues for new revenue streams for the organization in the industry. This can help Mccance Immulogic to build a more holistic ecosystem as suggested in the ImmuLogic Pharmaceutical Corp. (B2): Henry McCance case study. Mccance Immulogic can build new products and services such as - data insight services, data privacy related products, data based consulting services, etc.
Developing new processes and practices
– Mccance Immulogic can develop new processes and procedures in Finance & Accounting industry using technology such as automation using artificial intelligence, real time transportation and products tracking, 3D modeling for concept development and new products pilot testing etc.
Threats ImmuLogic Pharmaceutical Corp. (B2): Henry McCance External Strategic Factors
What are Threats in the SWOT Analysis / TOWS Matrix / Weighted SWOT Analysis
The threats mentioned in the HBR case study ImmuLogic Pharmaceutical Corp. (B2): Henry McCance are -
Consumer confidence and its impact on Mccance Immulogic demand
– There is a high probability of declining consumer confidence, given – high inflammation rate, rise of gig economy, lower job stability, increasing cost of living, higher interest rates, and aging demography. All the factors contribute to people saving higher rate of their income, resulting in lower consumer demand in the industry and other sectors.
Shortening product life cycle
– it is one of the major threat that Mccance Immulogic is facing in Finance & Accounting sector. It can lead to higher research and development costs, higher marketing expenses, lower customer loyalty, etc.
Instability in the European markets
– European Union markets are facing three big challenges post Covid – expanded balance sheets, Brexit related business disruption, and aggressive Russia looking to distract the existing security mechanism. Mccance Immulogic will face different problems in different parts of Europe. For example it will face inflationary pressures in UK, France, and Germany, balance sheet expansion and demand challenges in Southern European countries, and geopolitical instability in the Eastern Europe.
Capital market disruption
– During the Covid-19, Dow Jones has touched record high. The valuations of a number of companies are way beyond their existing business model potential. This can lead to capital market correction which can put a number of suppliers, collaborators, value chain partners in great financial difficulty. It will directly impact the business of Mccance Immulogic.
Aging population
– As the populations of most advanced economies are aging, it will lead to high social security costs, higher savings among population, and lower demand for goods and services in the economy. The household savings in US, France, UK, Germany, and Japan are growing faster than predicted because of uncertainty caused by pandemic.
Barriers of entry lowering
– As technology is more democratized, the barriers to entry in the industry are lowering. It can presents Mccance Immulogic with greater competitive threats in the near to medium future. Secondly it will also put downward pressure on pricing throughout the sector.
Technology disruption because of hacks, piracy etc
– The colonial pipeline illustrated, how vulnerable modern organization are to international hackers, miscreants, and disruptors. The cyber security interruption, data leaks, etc can seriously jeopardize the future growth of the organization.
Learning curve for new practices
– As the technology based on artificial intelligence and machine learning platform is getting complex, as highlighted in case study ImmuLogic Pharmaceutical Corp. (B2): Henry McCance, Mccance Immulogic may face longer learning curve for training and development of existing employees. This can open space for more nimble competitors in the field of Finance & Accounting .
Increasing international competition and downward pressure on margins
– Apart from technology driven competitive advantage dilution, Mccance Immulogic can face downward pressure on margins from increasing competition from international players. The international players have stable revenue in their home market and can use those resources to penetrate prominent markets illustrated in HBR case study ImmuLogic Pharmaceutical Corp. (B2): Henry McCance .
Environmental challenges
– Mccance Immulogic needs to have a robust strategy against the disruptions arising from climate change and energy requirements. EU has identified it as key priority area and spending 30% of its 880 billion Euros European post Covid-19 recovery funds on green technology. Mccance Immulogic can take advantage of this fund but it will also bring new competitors in the Finance & Accounting industry.
Easy access to finance
– Easy access to finance in Finance & Accounting field will also reduce the barriers to entry in the industry, thus putting downward pressure on the prices because of increasing competition. Mccance Immulogic can utilize it by borrowing at lower rates and invest it into research and development, capital expenditure to fortify its core competitive advantage.
High dependence on third party suppliers
– Mccance Immulogic high dependence on third party suppliers can disrupt its processes and delivery mechanism. For example -the current troubles of car makers because of chip shortage is because the chip companies started producing chips for electronic companies rather than car manufacturers.
High level of anxiety and lack of motivation
– the Great Resignation in United States is the sign of broader dissatisfaction among the workforce in United States. Mccance Immulogic needs to understand the core reasons impacting the Finance & Accounting industry. This will help it in building a better workplace.
Weighted SWOT Analysis of ImmuLogic Pharmaceutical Corp. (B2): Henry McCance Template, Example
Not all factors mentioned under the Strengths, Weakness, Opportunities, and Threats quadrants in the SWOT Analysis are equal. Managers in the HBR case study ImmuLogic Pharmaceutical Corp. (B2): Henry McCance needs to zero down on the relative importance of each factor mentioned in the Strengths, Weakness, Opportunities, and Threats quadrants.
We can provide the relative importance to each factor by assigning relative weights. Weighted SWOT analysis process is a three stage process –
First stage for doing weighted SWOT analysis of the case study ImmuLogic Pharmaceutical Corp. (B2): Henry McCance is to rank the strengths and weaknesses of the organization. This will help you to assess the most important strengths and weaknesses of the firm and which one of the strengths and weaknesses mentioned in the initial lists are marginal and can be left out.
Second stage for conducting weighted SWOT analysis of the Harvard case study ImmuLogic Pharmaceutical Corp. (B2): Henry McCance is to give probabilities to the external strategic factors thus better understanding the opportunities and threats arising out of macro environment changes and developments.
Third stage of constructing weighted SWOT analysis of ImmuLogic Pharmaceutical Corp. (B2): Henry McCance is to provide strategic recommendations includes – joining likelihood of external strategic factors such as opportunities and threats to the internal strategic factors – strengths and weaknesses. You should start with external factors as they will provide the direction of the overall industry. Secondly by joining probabilities with internal strategic factors can help the company not only strategic fit but also the most probably strategic trade-off that Mccance Immulogic needs to make to build a sustainable competitive advantage.